[go: up one dir, main page]

CN111285815A - Pyrazinamide compound and application thereof - Google Patents

Pyrazinamide compound and application thereof Download PDF

Info

Publication number
CN111285815A
CN111285815A CN201811496730.XA CN201811496730A CN111285815A CN 111285815 A CN111285815 A CN 111285815A CN 201811496730 A CN201811496730 A CN 201811496730A CN 111285815 A CN111285815 A CN 111285815A
Authority
CN
China
Prior art keywords
compound
general formula
configuration
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811496730.XA
Other languages
Chinese (zh)
Inventor
王刚
杨辉斌
兰杰
郝泽生
李志念
陈霖
李斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Sinochem Agrochemicals R&D Co Ltd
Original Assignee
Shenyang Sinochem Agrochemicals R&D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Sinochem Agrochemicals R&D Co Ltd filed Critical Shenyang Sinochem Agrochemicals R&D Co Ltd
Priority to CN201811496730.XA priority Critical patent/CN111285815A/en
Publication of CN111285815A publication Critical patent/CN111285815A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/601,4-Diazines; Hydrogenated 1,4-diazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention belongs to the field of bactericides. Relates to a pyrazinamide compound and a sterilization application thereof. The pyrazinamide compound is shown as a general formula I:

Description

一种吡嗪酰胺类化合物及用途A kind of pyrazinamide compound and use

技术领域technical field

本发明属于杀菌剂领域。涉及一种吡嗪酰胺类化合物及其杀菌用途。The present invention belongs to the field of fungicides. The invention relates to a pyrazinamide compound and its bactericidal use.

背景技术Background technique

由于杀菌剂在使用一段时间后,病害会对其产生抗性,因此,需要不断发明新型的和改进的具有杀菌活性的化合物和组合物。Since diseases can develop resistance to fungicides over a period of time, there is a continuing need to invent new and improved compounds and compositions with fungicidal activity.

酰胺化合物的杀菌活性已有报道。如WO2015074614A1公开了化合物KC(专利中化合物9)及其杀菌活性。The bactericidal activity of amide compounds has been reported. For example, WO2015074614A1 discloses compound KC (compound 9 in the patent) and its bactericidal activity.

Figure BDA0001897067810000011
Figure BDA0001897067810000011

现有技术中,结构如本发明通式I所示的吡嗪酰胺类化合物未见报道。In the prior art, there is no report on the pyrazinamide compounds whose structure is shown in the general formula I of the present invention.

发明内容SUMMARY OF THE INVENTION

本发明的目的在于提供一种杀菌活性更好的吡嗪酰胺类化合物,它可应用于农业上病害的防治。The purpose of the present invention is to provide a pyrazinamide compound with better bactericidal activity, which can be applied to the prevention and treatment of agricultural diseases.

为实现上述目的,本发明的技术方案如下:For achieving the above object, technical scheme of the present invention is as follows:

吡嗪酰胺类化合物如通式I所示,Pyrazinamide compounds are shown in general formula I,

Figure BDA0001897067810000012
Figure BDA0001897067810000012

式中:where:

R1选自氢、卤素、硝基、氰基、C1-C12的烷基或C1-C12的卤代烷基;R 1 is selected from hydrogen, halogen, nitro, cyano, C 1 -C 12 alkyl or C 1 -C 12 haloalkyl;

R2选自C1-C12的烷基;R 2 is selected from C 1 -C 12 alkyl;

所述通式I所示化合物还可为手性化合物,手性化合物构型选自R构型、S构型或RS混合构型。The compound represented by the general formula I can also be a chiral compound, and the configuration of the chiral compound is selected from R configuration, S configuration or RS mixed configuration.

本发明中优选的技术方案为,通式I中:Preferred technical scheme in the present invention is, in general formula I:

R1选自氢、卤素、C1-C6的烷基或C1-C6的卤代烷基;R 1 is selected from hydrogen, halogen, C 1 -C 6 alkyl or C 1 -C 6 haloalkyl;

R2选自C1-C8的烷基;R 2 is selected from C 1 -C 8 alkyl;

或,通式I所示的手性化合物,所述手性化合物构型选自R构型、S构型或RS混合物。Or, the chiral compound represented by the general formula I, the configuration of the chiral compound is selected from R configuration, S configuration or RS mixture.

本发明中进一步优选的技术方案为,通式I中:Further preferred technical scheme in the present invention is, in general formula I:

R1选自氢、氟、氯、溴、碘、甲基、乙基、丙基、异丙基、二氟甲基、三氟甲基、五氟乙基或七氟异丙基;R 1 is selected from hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, pentafluoroethyl or heptafluoroisopropyl;

R2选自甲基、乙基、丙基、异丙基、丁基、2-丁基、戊基、2-戊基、己基或2-己基,;R is selected from methyl, ethyl, propyl, isopropyl, butyl, 2 -butyl, pentyl, 2-pentyl, hexyl or 2-hexyl,;

或,通式I所示的手性化合物,所述手性化合物构型选自R构型、S构型或RS混合物。Or, the chiral compound represented by the general formula I, the configuration of the chiral compound is selected from R configuration, S configuration or RS mixture.

本发明中特别优选的技术方案为,通式I中:Particularly preferred technical scheme in the present invention is, in general formula I:

R1选自氢、氟、氯、溴、甲基或三氟甲基;R 1 is selected from hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl;

R2选自2-戊基或2-己基;R 2 is selected from 2-pentyl or 2-hexyl;

或,通式I所示的手性化合物,所述手性化合物构型选自R构型,S构型或RS混合物。Or, the chiral compound represented by the general formula I, the configuration of the chiral compound is selected from R configuration, S configuration or RS mixture.

上面给出的通式I化合物的定义中,汇集所用术语一般定义如下:In the definitions of compounds of general formula I given above, the terms used collectively are generally defined as follows:

烷基是指直链或支链形式,例如甲基、乙基、正丙基、异丙基等。卤代烷基是指烷基被一个或多个卤原子取代的基团,如氯乙基、三氟甲基、二氟甲基、七氟异丙基等。卤素是指氟、氯、溴、碘。Alkyl refers to straight or branched chain forms such as methyl, ethyl, n-propyl, isopropyl, and the like. Haloalkyl refers to a group in which the alkyl group is substituted with one or more halogen atoms, such as chloroethyl, trifluoromethyl, difluoromethyl, heptafluoroisopropyl, and the like. Halogen means fluorine, chlorine, bromine, iodine.

通式I化合物的制备方法,除另有注明外,反应式中各基团定义同前。The preparation method of the compound of general formula I, unless otherwise noted, the definitions of each group in the reaction formula are the same as before.

Figure BDA0001897067810000021
Figure BDA0001897067810000021

式中,L代表离去基团。In the formula, L represents a leaving group.

通式II化合物与通式III化合物(市售)在适宜的溶剂中、适宜的碱存在下,温度为-10℃到适宜溶剂的沸点下反应0.5-48小时制得化合物I。Compound I is prepared by reacting the compound of general formula II with the compound of general formula III (commercially available) in a suitable solvent and in the presence of a suitable base at a temperature of -10°C to the boiling point of the suitable solvent for 0.5-48 hours.

适宜的溶剂选自二氯甲烷、氯仿、四氯化碳、己烷、苯、甲苯、乙酸乙酯、乙腈、四氢呋喃、二氧六环、N,N-二甲基甲酰胺或二甲基亚砜等。Suitable solvents are selected from methylene chloride, chloroform, carbon tetrachloride, hexane, benzene, toluene, ethyl acetate, acetonitrile, tetrahydrofuran, dioxane, N,N-dimethylformamide or dimethylmethylene Sulfone etc.

适宜的碱包括碱金属如锂、钠或钾的氢化合物如氢化钠,碱金属如锂、钠或钾的氢氧化物如氢氧化钠,还可以是碱金属的碳酸盐如碳酸钠,也可以是有机碱如三乙胺、叔丁醇钠等。Suitable bases include alkali metal such as lithium, sodium or potassium hydrogen compounds such as sodium hydride, alkali metal such as lithium, sodium or potassium hydroxide such as sodium hydroxide, and also alkali metal carbonates such as sodium carbonate, It can be an organic base such as triethylamine, sodium tert-butoxide and the like.

通式II化合物为市售试剂或由其对应的酸制得。Compounds of general formula II are commercially available reagents or prepared from their corresponding acids.

通式III化合物可参考下列文献制备:Bioorganic&Medicinal Chemistry,2012,20(3):1213-1221;WO2005117909;农药,2007,46(5):307-309.The compound of general formula III can be prepared by referring to the following documents: Bioorganic & Medicinal Chemistry, 2012, 20(3): 1213-1221; WO2005117909; Pesticide, 2007, 46(5): 307-309.

表1列出了部分通式I化合物的结构和物理性质。Table 1 lists the structures and physical properties of some of the compounds of general formula I.

Figure BDA0001897067810000022
Figure BDA0001897067810000022

表1部分通式I化合物的结构和物理性质Table 1 Partial Structure and Physical Properties of Compounds of Formula I

Figure BDA0001897067810000023
Figure BDA0001897067810000023

Figure BDA0001897067810000031
Figure BDA0001897067810000031

Figure BDA0001897067810000041
Figure BDA0001897067810000041

Figure BDA0001897067810000051
Figure BDA0001897067810000051

Figure BDA0001897067810000061
Figure BDA0001897067810000061

Figure BDA0001897067810000071
Figure BDA0001897067810000071

Figure BDA0001897067810000081
Figure BDA0001897067810000081

Figure BDA0001897067810000091
Figure BDA0001897067810000091

Figure BDA0001897067810000101
Figure BDA0001897067810000101

Figure BDA0001897067810000111
Figure BDA0001897067810000111

Figure BDA0001897067810000121
Figure BDA0001897067810000121

Figure BDA0001897067810000131
Figure BDA0001897067810000131

Figure BDA0001897067810000141
Figure BDA0001897067810000141

Figure BDA0001897067810000151
Figure BDA0001897067810000151

部分化合物的1H NMR(600MHz,CDCl3)数据如下:The 1 H NMR (600 MHz, CDCl 3 ) data of some compounds are as follows:

化合物6:9.93(s,1H),8.67(d,J=2.3Hz,1H),8.45(d,J=2.1Hz,1H),7.78(d,J=8.2Hz,1H),7.23(t,J=8.2Hz,1H),6.74(d,J=8.2Hz,1H),3.86(s,3H),3.07(s,3H),2.25(s,3H).Compound 6: 9.93(s, 1H), 8.67(d, J=2.3Hz, 1H), 8.45(d, J=2.1Hz, 1H), 7.78(d, J=8.2Hz, 1H), 7.23(t, J=8.2Hz, 1H), 6.74(d, J=8.2Hz, 1H), 3.86(s, 3H), 3.07(s, 3H), 2.25(s, 3H).

化合物43:9.92(s,1H),8.67(d,J=2.3Hz,1H),8.46(d,J=2.2Hz,1H),7.77(d,J=8.1Hz,1H),7.20(t,J=8.2Hz,1H),6.72(d,J=8.2Hz,1H),4.06(q,J=7.0Hz,2H),3.07(s,3H),2.25(s,3H).Compound 43: 9.92(s, 1H), 8.67(d, J=2.3Hz, 1H), 8.46(d, J=2.2Hz, 1H), 7.77(d, J=8.1Hz, 1H), 7.20(t, J=8.2Hz, 1H), 6.72(d, J=8.2Hz, 1H), 4.06(q, J=7.0Hz, 2H), 3.07(s, 3H), 2.25(s, 3H).

化合物117:9.91(s,1H),8.66(d,J=2.3Hz,1H),8.45(d,J=2.0Hz,1H),7.76(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),6.74(d,J=8.2Hz,1H),4.53(dt,J1=12.1Hz,J2=6.0Hz,1H),3.07(s,3H),2.24(s,3H),1.35(d,J=6.1Hz,6H).Compound 117: 9.91(s, 1H), 8.66(d, J=2.3Hz, 1H), 8.45(d, J=2.0Hz, 1H), 7.76(d, J=8.1Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.74(d, J=8.2Hz, 1H), 4.53(dt, J1 = 12.1Hz , J2=6.0Hz, 1H), 3.07(s, 3H), 2.24(s, 3H),1.35(d,J=6.1Hz,6H).

化合物191:9.91(s,1H),8.66(d,J=2.3Hz,1H),8.45(d,J=2.1Hz,1H),7.75(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),6.73(d,J=8.2Hz,1H),4.32(dt,J1=12.0Hz,J2=6.0Hz,1H),3.07(s,3H),2.24(s,3H),1.83-1.72(m,1H),1.71-1.61(m,1H),1.30(d,J=6.1Hz,3H),0.99(t,J=7.5Hz,3H).Compound 191: 9.91(s, 1H), 8.66(d, J=2.3Hz, 1H), 8.45(d, J=2.1Hz, 1H), 7.75(d, J=8.1Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.73(d, J=8.2Hz, 1H), 4.32(dt, J1 = 12.0Hz, J2=6.0Hz, 1H ) , 3.07(s, 3H), 2.24(s, 3H), 1.83-1.72(m, 1H), 1.71-1.61(m, 1H), 1.30(d, J=6.1Hz, 3H), 0.99(t, J=7.5Hz, 3H).

化合物260:9.71(s,1H),9.52(d,J=1.3Hz,1H),8.81(d,J=2.4Hz,1H),8.61-8.59(m,1H),7.81(d,J=8.1Hz,1H),7.20(t,J=8.2Hz,1H),6.74(d,J=8.2Hz,1H),4.39(dd,J1=12.1Hz,J2=6.1Hz,1H),2.26(s,3H),1.80-1.72(m,1H),1.62-1.54(m,1H),1.53-1.38(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).Compound 260: 9.71(s, 1H), 9.52(d, J=1.3Hz, 1H), 8.81(d, J=2.4Hz, 1H), 8.61-8.59(m, 1H), 7.81(d, J=8.1 Hz, 1H), 7.20(t, J=8.2Hz, 1H), 6.74(d, J=8.2Hz, 1H), 4.39(dd, J1 = 12.1Hz , J2=6.1Hz, 1H), 2.26( s,3H),1.80-1.72(m,1H),1.62-1.54(m,1H),1.53-1.38(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J= 7.4Hz, 3H).

化合物262:9.56(s,1H),8.61(d,J=2.3Hz,1H),8.57(d,J=2.3Hz,1H),7.77(d,J=8.1Hz,1H),7.20(t,J=8.2Hz,1H),6.75(d,J=8.2Hz,1H),4.39(dd,J1=12.1Hz,J2=6.1Hz,1H),2.23(s,3H),1.80-1.70(m,1H),1.63-1.54(m,1H),1.53-1.37(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.3Hz,3H).Compound 262: 9.56(s, 1H), 8.61(d, J=2.3Hz, 1H), 8.57(d, J=2.3Hz, 1H), 7.77(d, J=8.1Hz, 1H), 7.20(t, J=8.2Hz,1H),6.75(d,J=8.2Hz,1H),4.39(dd,J1 = 12.1Hz ,J2=6.1Hz,1H),2.23(s,3H),1.80-1.70( m, 1H), 1.63-1.54 (m, 1H), 1.53-1.37 (m, 2H), 1.30 (d, J=6.1Hz, 3H), 0.95 (t, J=7.3Hz, 3H).

化合物265:8.66(s,1H),8.45(s,1H),7.74(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),6.73(d,J=8.3Hz,1H),4.38(dd,J1=12.1Hz,J2=6.0Hz,1H),3.07(s,3H),2.24(s,3H),1.81-1.67(m,1H),1.62-1.54(m,1H),1.53-1.37(m,2H),1.30(d,J=6.0Hz,3H),0.95(t,J=7.3Hz,3H).Compound 265: 8.66 (s, 1H), 8.45 (s, 1H), 7.74 (d, J=8.1 Hz, 1H), 7.19 (t, J=8.2 Hz, 1H), 6.73 (d, J=8.3 Hz, 1H), 4.38(dd, J 1 =12.1Hz, J 2 =6.0Hz, 1H), 3.07(s, 3H), 2.24(s, 3H), 1.81-1.67(m, 1H), 1.62-1.54(m ,1H),1.53-1.37(m,2H),1.30(d,J=6.0Hz,3H),0.95(t,J=7.3Hz,3H).

化合物270:9.38(s,1H),8.88(d,J=2.2Hz,1H),8.82(d,J=2.2Hz,1H),7.74(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),6.75(d,J=8.2Hz,1H),4.39(dd,J1=12.1Hz,J2=6.1Hz,1H),2.24(s,3H),1.81-1.70(m,1H),1.64-1.53(m,1H),1.51-1.38(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).Compound 270: 9.38(s, 1H), 8.88(d, J=2.2Hz, 1H), 8.82(d, J=2.2Hz, 1H), 7.74(d, J=8.1Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.75(d, J=8.2Hz, 1H), 4.39(dd, J1 = 12.1Hz , J2=6.1Hz, 1H), 2.24(s, 3H), 1.81-1.70( m, 1H), 1.64-1.53 (m, 1H), 1.51-1.38 (m, 2H), 1.30 (d, J=6.1Hz, 3H), 0.95 (t, J=7.4Hz, 3H).

化合物274:9.51(s,1H),9.28(s,1H),8.60(s,1H),7.76(d,J=8.1Hz,1H),7.20(t,J=8.2Hz,1H),6.75(d,J=8.3Hz,1H),4.39(dd,J1=12.1Hz,J2=6.1Hz,1H),2.24(s,3H),1.83-1.69(m,1H),1.62-1.55(m,1H),1.53-1.39(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).Compound 274: 9.51(s, 1H), 9.28(s, 1H), 8.60(s, 1H), 7.76(d, J=8.1Hz, 1H), 7.20(t, J=8.2Hz, 1H), 6.75( d, J=8.3Hz, 1H), 4.39 (dd, J1 = 12.1Hz, J2=6.1Hz, 1H), 2.24(s, 3H), 1.83-1.69 (m, 1H), 1.62-1.55(m ,1H),1.53-1.39(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).

化合物277:9.67(s,1H),9.38(s,1H),8.46(s,1H),7.81(d,J=8.1Hz,1H),7.20(t,J=8.2Hz,1H),6.73(d,J=8.2Hz,1H),4.39(dd,J1=12.1Hz,J2=6.1Hz,1H),2.69(s,3H),2.25(s,3H),1.80-1.71(m,1H),1.62-1.54(m,1H),1.53-1.39(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.3Hz,3H).Compound 277: 9.67(s, 1H), 9.38(s, 1H), 8.46(s, 1H), 7.81(d, J=8.1Hz, 1H), 7.20(t, J=8.2Hz, 1H), 6.73( d, J=8.2Hz, 1H), 4.39 (dd, J1 = 12.1Hz, J2=6.1Hz, 1H), 2.69(s, 3H), 2.25 (s, 3H), 1.80-1.71(m, 1H) ),1.62-1.54(m,1H),1.53-1.39(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.3Hz,3H).

化合物286:9.42(s,1H),9.39(s,1H),8.80(s,1H),7.69(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),4.39(dd,J1=12.1Hz,J2=6.0Hz,1H),2.24(s,4H),1.82-1.71(m,1H),1.62-1.55(m,1H),1.52-1.39(m,3H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).Compound 286: 9.42(s, 1H), 9.39(s, 1H), 8.80(s, 1H), 7.69(d, J=8.1Hz, 1H), 7.19(t, J=8.2Hz, 1H), 4.39( dd, J 1 =12.1Hz, J 2 =6.0Hz, 1H), 2.24(s, 4H), 1.82-1.71(m, 1H), 1.62-1.55(m, 1H), 1.52-1.39(m, 3H) ,1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).

化合物289:9.77(s,1H),9.31(s,1H),8.67(s,1H),7.79(d,J=8.1Hz,1H),7.20(t,J=8.2Hz,1H),6.74(d,J=8.2Hz,1H),4.39(dd,J1=12.0Hz,J2=6.0Hz,1H),2.67(s,3H),2.26(s,3H),1.80-1.72(m,1H),1.63-1.54(m,1H),1.52-1.39(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.3Hz,3H).Compound 289: 9.77(s, 1H), 9.31(s, 1H), 8.67(s, 1H), 7.79(d, J=8.1Hz, 1H), 7.20(t, J=8.2Hz, 1H), 6.74( d,J=8.2Hz,1H),4.39(dd,J1 = 12.0Hz,J2=6.0Hz,1H ) ,2.67(s,3H),2.26(s,3H),1.80-1.72(m,1H) ),1.63-1.54(m,1H),1.52-1.39(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.3Hz,3H).

化合物334:9.71(s,1H),9.52(d,J=0.8Hz,1H),8.81(d,J=1.6Hz,1H),8.61-8.60(m,1H),7.81(d,J=5.2Hz,1H),7.20(t,J=5.6Hz,1H),6.74(d,J=5.6Hz,1H),4.39-4.36(m,1H),2.26(s,3H),1.80-1.72(m,2H),1.62-1.54(m,2H),1.53-1.38(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).Compound 334: 9.71(s,1H), 9.52(d,J=0.8Hz,1H), 8.81(d,J=1.6Hz,1H), 8.61-8.60(m,1H), 7.81(d,J=5.2 Hz, 1H), 7.20(t, J=5.6Hz, 1H), 6.74(d, J=5.6Hz, 1H), 4.39-4.36(m, 1H), 2.26(s, 3H), 1.80-1.72(m ,2H),1.62-1.54(m,2H),1.53-1.38(m,2H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.4Hz,3H).

化合物336:9.56(s,1H),8.60(d,J=2.3Hz,1H),8.57(d,J=2.3Hz,1H),7.77(d,J=8.3Hz,1H),7.19(t,J=8.2Hz,1H),6.74(d,J=8.4Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),2.24(d,J=3.1Hz,3H),1.80-1.73(m,1H),1.72-1.65(m,1H),1.64-1.57(m,1H),1.51-1.41(m,1H),1.40-1.32(m,2H),1.30(d,J=6.1Hz,3H),0.91(t,J=7.1Hz,3H).Compound 336: 9.56(s, 1H), 8.60(d, J=2.3Hz, 1H), 8.57(d, J=2.3Hz, 1H), 7.77(d, J=8.3Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.74 (d, J=8.4Hz, 1H), 4.37 (dd, J1 = 12.1Hz , J2=6.1Hz, 1H), 2.24 (d, J=3.1Hz, 3H) ,1.80-1.73(m,1H),1.72-1.65(m,1H),1.64-1.57(m,1H),1.51-1.41(m,1H),1.40-1.32(m,2H),1.30(d, J=6.1Hz, 3H), 0.91(t, J=7.1Hz, 3H).

化合物339:9.91(s,1H),8.66(d,J=2.3Hz,1H),8.45(d,J=2.1Hz,1H),7.75(d,J=8.3Hz,1H),7.19(t,J=8.2Hz,1H),6.73(d,J=8.3Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),3.07(s,3H),2.24(s,2H),1.80-1.74(m,1H),1.72-1.66(m,1H),1.65-1.58(m,1H),1.48-1.41(m,1H),1.40-1.33(m,2H),1.30(d,J=6.1Hz,3H),0.91(t,J=7.1Hz,3H).Compound 339: 9.91(s, 1H), 8.66(d, J=2.3Hz, 1H), 8.45(d, J=2.1Hz, 1H), 7.75(d, J=8.3Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.73(d, J=8.3Hz, 1H), 4.37(dd, J1 = 12.1Hz , J2=6.1Hz, 1H), 3.07(s, 3H), 2.24(s, 2H), 1.80-1.74(m, 1H), 1.72-1.66(m, 1H), 1.65-1.58(m, 1H), 1.48-1.41(m, 1H), 1.40-1.33(m, 2H), 1.30( d,J=6.1Hz,3H),0.91(t,J=7.1Hz,3H).

化合物344:9.38(s,1H),8.88(d,J=2.2Hz,1H),8.82(d,J=2.2Hz,1H),7.74(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),6.75(d,J=8.4Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),2.24(d,J=3.1Hz,3H),1.81-1.73(m,1H),1.71-1.67(m,1H),1.66-1.57(m,1H),1.49-1.41(m,1H),1.40-1.32(m,2H),1.30(d,J=6.1Hz,3H),0.91(t,J=7.1Hz,3H).Compound 344: 9.38(s, 1H), 8.88(d, J=2.2Hz, 1H), 8.82(d, J=2.2Hz, 1H), 7.74(d, J=8.1Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.75 (d, J=8.4Hz, 1H), 4.37 (dd, J1 = 12.1Hz , J2=6.1Hz, 1H), 2.24 (d, J=3.1Hz, 3H) ,1.81-1.73(m,1H),1.71-1.67(m,1H),1.66-1.57(m,1H),1.49-1.41(m,1H),1.40-1.32(m,2H),1.30(d, J=6.1Hz, 3H), 0.91(t, J=7.1Hz, 3H).

化合物348:9.51(s,1H),9.27(s,1H),8.58(s,1H),7.75(t,J=7.9Hz,1H),7.19(t,J=8.2Hz,1H),6.73(t,J=7.9Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),2.24(d,J=4.0Hz,3H),1.78-1.74(m,1H),1.72-1.66(m,1H),1.64-1.55(m,1H),1.49-1.41(m,1H),1.40-1.33(m,2H),1.30(d,J=6.1Hz,3H),0.92(t,J=7.1Hz,3H).Compound 348: 9.51(s, 1H), 9.27(s, 1H), 8.58(s, 1H), 7.75(t, J=7.9Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.73( t,J=7.9Hz,1H),4.37(dd,J1 = 12.1Hz,J2=6.1Hz,1H),2.24(d,J=4.0Hz,3H), 1.78-1.74 (m,1H), 1.72-1.66(m, 1H), 1.64-1.55(m, 1H), 1.49-1.41(m, 1H), 1.40-1.33(m, 2H), 1.30(d, J=6.1Hz, 3H), 0.92( t,J=7.1Hz,3H).

化合物351:9.67(s,1H),9.37(d,J=1.0Hz,1H),8.45(s,1H),7.80(t,J=8.1Hz,1H),7.19(td,J1=8.2Hz,J2=2.9Hz,1H),6.72(t,J=8.1Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),2.68(s,3H),2.25(d,J=3.7Hz,3H),1.81-1.73(m,1H),1.72-1.66(m,1H),1.65-1.54(m,1H),1.50-1.41(m,1H),1.39-1.32(m,2H),1.30(d,J=6.1Hz,3H),0.91(t,J=7.1Hz,3H).Compound 351: 9.67 (s, 1H), 9.37 (d, J=1.0 Hz, 1H), 8.45 (s, 1H), 7.80 (t, J=8.1 Hz, 1H), 7.19 (td, J 1 =8.2 Hz , J 2 =2.9Hz,1H),6.72(t,J=8.1Hz,1H),4.37(dd,J 1 =12.1Hz,J 2 =6.1Hz,1H),2.68(s,3H),2.25( d, J=3.7Hz, 3H), 1.81-1.73(m, 1H), 1.72-1.66(m, 1H), 1.65-1.54(m, 1H), 1.50-1.41(m, 1H), 1.39-1.32( m, 2H), 1.30(d, J=6.1Hz, 3H), 0.91(t, J=7.1Hz, 3H).

化合物360:9.42(s,1H),9.39(s,1H),8.80(s,1H),7.69(t,J=7.9Hz,1H),7.19(t,J=8.2Hz,1H),6.74(t,J=8.0Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),2.25(d,J=4.3Hz,3H),1.80-1.74(m,1H),1.72-1.68(m,1H),1.64-1.59(m,1H),1.49-1.42(m,1H),1.40-1.33(m,2H),1.30(d,J=6.1Hz,3H),0.92(t,J=7.1Hz,3H).Compound 360: 9.42(s, 1H), 9.39(s, 1H), 8.80(s, 1H), 7.69(t, J=7.9Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.74( t,J=8.0Hz,1H),4.37(dd,J1 = 12.1Hz,J2=6.1Hz,1H), 2.25 (d,J=4.3Hz,3H),1.80-1.74(m,1H), 1.72-1.68(m, 1H), 1.64-1.59(m, 1H), 1.49-1.42(m, 1H), 1.40-1.33(m, 2H), 1.30(d, J=6.1Hz, 3H), 0.92( t,J=7.1Hz,3H).

化合物363:9.78(s,1H),9.30(s,1H),8.66(s,1H),7.78(t,J=8.3Hz,1H),7.19(dd,J1=10.9Hz,J2=5.5Hz,1H),6.73(t,J=8.2Hz,1H),4.37(dd,J1=12.1Hz,J2=6.1Hz,1H),2.67(s,3H),2.26(d,J=4.1Hz,3H),1.82-1.74(m,1H),1.73-1.68(m,1H),1.66-1.57(m,1H),1.48-1.42(m,1H),1.40-1.33(m,2H),1.30(d,J=6.1Hz,3H),0.92(t,J=7.1Hz,3H).Compound 363: 9.78 (s, 1H), 9.30 (s, 1H), 8.66 (s, 1H), 7.78 (t, J=8.3 Hz, 1H), 7.19 (dd, J 1 =10.9 Hz, J 2 =5.5 Hz, 1H), 6.73(t, J=8.2Hz, 1H), 4.37(dd, J1 = 12.1Hz , J2=6.1Hz, 1H), 2.67(s, 3H), 2.26(d, J=4.1 Hz,3H),1.82-1.74(m,1H),1.73-1.68(m,1H),1.66-1.57(m,1H),1.48-1.42(m,1H),1.40-1.33(m,2H), 1.30(d,J=6.1Hz,3H),0.92(t,J=7.1Hz,3H).

化合物373191:9.91(s,1H),8.66(d,J=2.3Hz,1H),8.45(d,J=2.1Hz,1H),7.75(d,J=8.1Hz,1H),7.19(t,J=8.2Hz,1H),6.73(d,J=8.2Hz,1H),4.39(dt,J1=12.0Hz,J2=6.0Hz,1H),3.07(s,3H),2.24(s,3H),1.83-1.72(m,1H),1.71-1.61(m,1H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.5Hz,3H).Compound 373191: 9.91(s, 1H), 8.66(d, J=2.3Hz, 1H), 8.45(d, J=2.1Hz, 1H), 7.75(d, J=8.1Hz, 1H), 7.19(t, J=8.2Hz, 1H), 6.73(d, J=8.2Hz, 1H), 4.39(dt, J1 = 12.0Hz, J2=6.0Hz, 1H ) , 3.07(s, 3H), 2.24(s, 3H), 1.83-1.72(m, 1H), 1.71-1.61(m, 1H), 1.30(d, J=6.1Hz, 3H), 0.95(t, J=7.5Hz, 3H).

化合物374371191:9.91(s,1H),8.64(d,J=2.3Hz,1H),8.43(d,J=2.1Hz,1H),7.75(d,J=8.1Hz,1H),7.18(t,J=8.2Hz,1H),6.73(d,J=8.2Hz,1H),4.39(dt,J1=12.0Hz,J2=6.0Hz,1H),3.06(s,3H),2.24(s,3H),1.83-1.72(m,1H),1.71-1.61(m,1H),1.30(d,J=6.1Hz,3H),0.95(t,J=7.5Hz,3H).Compound 374371191: 9.91(s, 1H), 8.64(d, J=2.3Hz, 1H), 8.43(d, J=2.1Hz, 1H), 7.75(d, J=8.1Hz, 1H), 7.18(t, J=8.2Hz, 1H), 6.73(d, J=8.2Hz, 1H), 4.39(dt, J1 = 12.0Hz, J2=6.0Hz, 1H ) , 3.06(s, 3H), 2.24(s, 3H), 1.83-1.72(m, 1H), 1.71-1.61(m, 1H), 1.30(d, J=6.1Hz, 3H), 0.95(t, J=7.5Hz, 3H).

本发明还包括通式I化合物用于控制病害的用途,以防治卵菌纲(Oomycetes)、子囊菌纲(Ascomycetes)、担子菌纲(Basidiomycetes)、半知菌纲(Deuteromycetes)、根肿菌纲(Plasmodiophoromycetes)、壶菌纲(Chytridiomycetes)和结合菌亚纲(Zygomycetes)病害。The present invention also includes the use of compounds of general formula I for controlling diseases to control Oomycetes, Ascomycetes, Basidiomycetes, Deuteromycetes, Plasmorhizobium (Plasmodiophoromycetes), Chytridiomycetes and Zygomycetes diseases.

在上面列出的纲名下的某些病害的实例可提及的包括但不限于:Examples of certain diseases that may be mentioned under the class names listed above include, but are not limited to:

小麦锈病、小麦白粉病、小麦赤霉病、小麦根腐病、小麦纹枯病、小麦全蚀病、小麦颖枯病、黄瓜霜霉病、黄瓜炭疽病、黄瓜枯萎病、黄瓜灰霉病、葡萄霜霉病、番茄早疫病、番茄晚疫病、水稻纹枯病、水稻稻瘟病、西瓜蔓枯病、花生疮痂病、花生黑斑病、柑橘疮痂病、辣椒根腐病、棉花黄萎病、棉花枯萎病、油菜黑茎病、油菜菌核病、梨黑星病、人参锈腐病、玉米锈病、玉米弯孢病、玉米大斑病、芒果蒂腐病、苹果轮纹病、苹果腐菌烂病、香蕉叶斑病。Wheat rust, wheat powdery mildew, wheat scab, wheat root rot, wheat sheath blight, wheat take-all disease, wheat glume blight, cucumber downy mildew, cucumber anthracnose, cucumber fusarium wilt, cucumber gray mold, Grape downy mildew, tomato early blight, tomato late blight, rice sheath blight, rice blast, watermelon blight, peanut scab, peanut black spot, citrus scab, pepper root rot, cotton verticillium wilt, Cotton fusarium wilt, rape black stem disease, rape sclerotinia, pear scab, ginseng rust, corn rust, corn curvaceous disease, corn leaf spot, mango stalk rot, apple ring rot, apple rot fungus Rot, banana leaf spot.

本发明还包括以通式I化合物作为活性组分的杀菌组合物。该杀菌组合物中作为活性组分的通式I化合物的重量百分含量在1-99%之间。该杀菌组合物中还包括农业上可接受的载体。The present invention also includes fungicidal compositions comprising a compound of general formula I as an active ingredient. The weight percent content of the compound of formula I as an active component in the bactericidal composition is between 1-99%. An agriculturally acceptable carrier is also included in the fungicidal composition.

本发明的组合物可以制剂的形式施用。通式I化合物作为活性组分溶解或分散于载体中或配制成制剂以便作为杀菌使用时更易于分散。例如:这些化学制剂可被制成可湿性粉剂或乳油。在这些组合物中,至少加入一种液体或固体载体,并且当需要时可以加入适当的表面活性剂。The compositions of the present invention can be administered in the form of formulations. The compound of formula I is dissolved or dispersed as the active ingredient in a carrier or formulated so as to be easier to disperse for bactericidal use. For example, these chemicals can be formulated as wettable powders or emulsifiable concentrates. In these compositions, at least one liquid or solid carrier is added, and when desired, suitable surfactants can be added.

本发明的技术方案还包括防治病害的方法:将本发明的杀菌组合物施于所述的病害或其生长介质上。通常选择的较为适宜的有效量为每公顷10克到1000克。The technical solution of the present invention also includes a method for preventing and treating diseases: applying the bactericidal composition of the present invention to the disease or its growth medium. A more suitable effective amount is usually selected from 10 grams to 1000 grams per hectare.

对于某些应用,例如在农业上可在本发明的杀菌组合物中加入一种或多种其它的杀虫剂、杀菌剂、除草剂、植物生长调节剂或肥料等,由此可产生附加的优点和效果。For certain applications, such as in agriculture, one or more other insecticides, fungicides, herbicides, plant growth regulators or fertilizers, etc. may be added to the fungicidal compositions of the present invention, thereby producing additional Advantages and Effects.

本发明所具有的优点:The advantages of the present invention:

同已知的吡嗪酰胺类化合物相比,本发明化合物结构新颖,并且本发明的吡嗪酰胺类化合物具有意想不到的高杀菌活性,在较低剂量下也具有高的杀菌活性,不仅高效,而且减少了农药的使用量,降低了成本,减少了对环境的污染。Compared with the known pyrazinamide compounds, the compound of the present invention has a novel structure, and the pyrazinamide compound of the present invention has an unexpected high bactericidal activity, and also has a high bactericidal activity at a lower dose, and is not only efficient, Moreover, the use of pesticides is reduced, the cost is reduced, and the pollution to the environment is reduced.

具体实施方式Detailed ways

下列合成实施例、生物活性测定实施例可用来进一步说明本发明,但不意味着限制本发明。The following synthesis examples and biological activity assay examples can be used to further illustrate the present invention, but are not intended to limit the present invention.

合成实施例Synthesis Example

实施例1化合物270的制备:Preparation of Example 1 Compound 270:

Figure BDA0001897067810000181
Figure BDA0001897067810000181

反应瓶中加入3-甲基吡嗪-2-甲酸(200毫克,1.04毫摩尔)、10毫升甲苯和1毫升氯化亚砜,回流反应2小时,旋除多余的氯化亚砜和溶剂备用。2-甲基-3-(戊基-2-氧基)苯胺(201毫克,1.04毫摩尔)溶于10毫升二氯甲烷,加入1毫升三乙胺。将制备好的酰氯溶于二氯甲烷,滴加到上述混合液中,常温反应2小时。反应液倾入至30毫升水中,二氯甲烷萃取三次,取有机层,有机层依次用饱和碳酸氢钠水溶液、饱和食盐水洗涤,无水硫酸镁干燥,减压蒸尽溶剂。残余物通过柱色谱提纯(淋洗液:乙酸乙酯:石油醚=1:5),得230毫克化合物270,收率55.7%。3-methylpyrazine-2-carboxylic acid (200 mg, 1.04 mmol), 10 ml of toluene and 1 ml of thionyl chloride were added to the reaction flask, and the reaction was refluxed for 2 hours, and the excess thionyl chloride and solvent were removed for use. . 2-Methyl-3-(pentyl-2-oxy)aniline (201 mg, 1.04 mmol) was dissolved in 10 mL of dichloromethane and 1 mL of triethylamine was added. The prepared acid chloride was dissolved in dichloromethane, added dropwise to the above mixture, and reacted at room temperature for 2 hours. The reaction solution was poured into 30 ml of water, extracted three times with dichloromethane, and the organic layer was taken. The organic layer was washed successively with saturated aqueous sodium bicarbonate solution and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography (eluent: ethyl acetate: petroleum ether=1:5) to obtain 230 mg of compound 270 in a yield of 55.7%.

实施例2化合物344的制备:Preparation of Example 2 Compound 344:

Figure BDA0001897067810000182
Figure BDA0001897067810000182

反应瓶中加入3-甲基吡嗪-2-甲酸(200毫克,1.04毫摩尔)、10毫升甲苯和1毫升氯化亚砜,回流反应2小时,旋除多余的氯化亚砜和溶剂备用。2-甲基-3-(己基-2-氧基)苯胺(216毫克,1.04毫摩尔)溶于10毫升二氯甲烷,加入1毫升三乙胺。将制备好的酰氯溶于二氯甲烷,滴加到上述混合液中,常温反应2小时。反应液倾入至30毫升水中,二氯甲烷萃取三次,取有机层,有机层依次用饱和碳酸氢钠水溶液、饱和食盐水洗涤,无水硫酸镁干燥,减压蒸尽溶剂。残余物通过柱色谱提纯(淋洗液:乙酸乙酯:石油醚=1:5),得190毫克化合物344,收率47.5%。3-methylpyrazine-2-carboxylic acid (200 mg, 1.04 mmol), 10 ml of toluene and 1 ml of thionyl chloride were added to the reaction flask, and the reaction was refluxed for 2 hours, and the excess thionyl chloride and solvent were removed for use. . 2-Methyl-3-(hexyl-2-oxy)aniline (216 mg, 1.04 mmol) was dissolved in 10 mL of dichloromethane and 1 mL of triethylamine was added. The prepared acid chloride was dissolved in dichloromethane, added dropwise to the above mixture, and reacted at room temperature for 2 hours. The reaction solution was poured into 30 ml of water, extracted three times with dichloromethane, and the organic layer was taken. The organic layer was washed successively with saturated aqueous sodium bicarbonate solution and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography (eluent: ethyl acetate: petroleum ether=1:5) to obtain 190 mg of compound 344 in a yield of 47.5%.

本发明的其他通式I化合物可参照上述方法合成。Other compounds of general formula I of the present invention can be synthesized by referring to the above-mentioned methods.

生物活性测定实施例Biological Activity Assay Example

实施例3杀菌活性的测定Example 3 Determination of bactericidal activity

用上述获得的本发明化合物对植物的多种病害进行了试验。试验的方法如下:The compounds of the present invention obtained above were tested against various diseases of plants. The test method is as follows:

(1)活体保护活性试验(1) In vivo protection activity test

试验采用盆栽幼苗测定法。选择生长一致的两叶期盆栽黄瓜幼苗作为黄瓜霜霉病的试验寄主植物;选择生长一致的两叶期盆栽小麦幼苗作为小麦白粉病的试验寄主植物,选择生长一致的两叶期盆栽玉米幼苗作为玉米锈病的试验寄主植物。用本发明化合物按照设计浓度进行叶面喷雾处理。另设喷清水的空白对照,3次重复,处理后第二天进行病害接种。接种后,将植物放在人工气候室中保湿培养(温度:昼25℃、夜20℃,相对湿度:95-99%)。试验材料培养24h后,移置温室培养,将不需要保湿培养的植物直接在温室内接种并培养。带对照充分发病后(通常为一周时间)进行化合物防病效果评估。结果调查参照美国植病学会编写的《A Manual of Assessment Keys for Plant Diseases》,用100~0来表示,以“100”级代表无病和“0”级代表最严重的发病程度。The test adopts the potted seedling assay method. The two-leaf stage potted cucumber seedlings with consistent growth were selected as the experimental host plants for cucumber downy mildew; the two-leaf stage potted wheat seedlings with consistent growth were selected as the test host plants for wheat powdery mildew, and the two-leaf stage potted maize seedlings with consistent growth were selected as the experimental host plants for cucumber downy mildew. Test host plants for maize rust. Foliar spray treatments were carried out with the compounds of the present invention at the designed concentrations. Another blank control with water spray was set up, repeated three times, and disease inoculation was carried out on the second day after treatment. After inoculation, the plants were placed in an artificial climate chamber for moisturizing cultivation (temperature: 25° C. day, 20° C. night, relative humidity: 95-99%). After culturing the test material for 24 hours, it was transferred to the greenhouse for cultivation, and the plants that did not require moisturizing cultivation were directly inoculated and cultivated in the greenhouse. The compound disease prevention effect was evaluated after sufficient disease onset (usually one week) with controls. Results The survey refers to the "A Manual of Assessment Keys for Plant Diseases" compiled by the American Society of Plant Diseases, with 100 to 0, where "100" represents no disease and "0" represents the most serious disease.

部分测试结果如下:Some of the test results are as follows:

对玉米锈病的防效:Prevention of corn rust:

按照以上测试方法,部分供试的化合物中,下列化合物在浓度为400ppm时对玉米锈病的防治效果较好,防效≥80%:化合物5、43、117、191、262、265、270、277、289、336、339、344、348、373和374。According to the above test method, among some of the tested compounds, the following compounds have better control effect on corn rust at a concentration of 400ppm, and the control effect is ≥80%: Compounds 5, 43, 117, 191, 262, 265, 270, 277 , 289, 336, 339, 344, 348, 373 and 374.

按照以上测试方法,选取化合物270和344与已知化合物KC进行了防治玉米锈病活性的平行测定。试验结果见表3。According to the above test method, the compounds 270 and 344 and the known compound KC were selected to carry out parallel determination of the control activity of corn rust. The test results are shown in Table 3.

表3:部分本发明化合物与已知化合物对玉米锈病防效的比较Table 3: Comparison of some compounds of the present invention and known compounds against corn rust

Figure BDA0001897067810000191
Figure BDA0001897067810000191

(2)离体抑菌活性试验(2) In vitro antibacterial activity test

测定方法如下:采用高通量筛选方法,即将待测化合物样品用适合的溶剂(溶剂的种类如丙酮、甲醇、DMF等,并依据其对样品的溶解能力而选择)溶剂,配成所需浓度待测液。在超净工作环境下,将待测液加入到96孔培养板的微孔中,再将病原菌繁殖体悬浮液加入其中,处理后的培养板放置在恒温培养箱中培养,24小时后进行调查。调查时目测病原菌繁殖体萌发或生长情况,并根据对照处理的萌发或生长情况,评价化合物抑菌活性。The determination method is as follows: using a high-throughput screening method, that is, using a suitable solvent (such as acetone, methanol, DMF, etc., and selecting the solvent according to its dissolving ability to the sample) for the sample of the compound to be tested to prepare the desired concentration liquid to be tested. In an ultra-clean working environment, the liquid to be tested was added to the microwells of a 96-well culture plate, and then the pathogenic bacteria propagule suspension was added to it, and the treated culture plate was placed in a constant temperature incubator for cultivation, and the investigation was carried out after 24 hours. . During the investigation, the germination or growth of the propagules of the pathogenic bacteria was visually observed, and the bacteriostatic activity of the compounds was evaluated according to the germination or growth of the control treatment.

部分化合物的离体抑菌活性(以抑制率表示)测试结果如下:The test results of in vitro antibacterial activity (expressed as inhibition rate) of some compounds are as follows:

水稻稻瘟病菌:Rice blast fungus:

部分供试的化合物中,下列化合物在浓度为25ppm时防治效果较好,抑制率≥80%:化合物260、265、277、289、334、339、351和363。Among some of the tested compounds, the following compounds have better control effects at a concentration of 25 ppm, and the inhibition rate is ≥80%: compounds 260, 265, 277, 289, 334, 339, 351 and 363.

Claims (8)

1.一种吡嗪酰胺类化合物,其特征在于:化合物如通式I所示:1. a pyrazinamide compound, is characterized in that: compound is as shown in general formula I:
Figure FDA0001897067800000011
Figure FDA0001897067800000011
式中:where: R1选自氢、卤素、硝基、氰基、C1-C12的烷基或C1-C12的卤代烷基;R 1 is selected from hydrogen, halogen, nitro, cyano, C 1 -C 12 alkyl or C 1 -C 12 haloalkyl; R2选自C1-C12的烷基。R 2 is selected from C 1 -C 12 alkyl.
2.按照权利要求1所述的化合物,其特征在于,所述通式I所示化合物还可为手性化合物,手性化合物构型选自R构型、S构型或RS混合构型。2 . The compound according to claim 1 , wherein the compound represented by the general formula I can also be a chiral compound, and the configuration of the chiral compound is selected from R configuration, S configuration or RS mixed configuration. 3 . 3.按照权利要求1或2所述的化合物,其特征在于,通式I中:3. according to the compound described in claim 1 or 2, it is characterized in that, in general formula I: R1选自氢、卤素、C1-C6的烷基或C1-C6的卤代烷基;R 1 is selected from hydrogen, halogen, C 1 -C 6 alkyl or C 1 -C 6 haloalkyl; R2选自C1-C8的烷基。R 2 is selected from C 1 -C 8 alkyl. 4.按照权利要求3所述的化合物,其特征在于,通式I中:4. according to the compound described in claim 3, it is characterized in that, in general formula I: R1选自氢、氟、氯、溴、碘、甲基、乙基、丙基、异丙基、二氟甲基、三氟甲基、五氟乙基或七氟异丙基;R 1 is selected from hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, pentafluoroethyl or heptafluoroisopropyl; R2选自甲基、乙基、丙基、异丙基、丁基、2-丁基、戊基、2-戊基、己基或2-己基。R2 is selected from methyl, ethyl, propyl, isopropyl, butyl, 2 -butyl, pentyl, 2-pentyl, hexyl or 2-hexyl. 5.按照权利要求4所述的化合物,其特征在于,通式I中:5. compound according to claim 4 is characterized in that, in general formula I: R1选自氢、氟、氯、溴、甲基或三氟甲基;R 1 is selected from hydrogen, fluorine, chlorine, bromine, methyl or trifluoromethyl; R2选自2-戊基或2-己基。R 2 is selected from 2-pentyl or 2-hexyl. 6.一种按照权利要求1所述的吡嗪酰胺类化合物的应用,其特征在于:所述通式I化合物用于制备控制农业、林业或非治疗目的植物病害的药物。6 . The application of the pyrazinamide compound according to claim 1 , wherein the compound of general formula I is used to prepare a medicine for controlling agricultural, forestry or non-therapeutic plant diseases. 7 . 7.一种杀菌组合物,其特征在于:杀菌组合物是以权利要求1所述的通式I所示化合物为活性组分和农业或林业可接受的载体,组合物中作为活性组分的通式I化合物的重量含量为1-99%。7. a bactericidal composition is characterized in that: the bactericidal composition is the acceptable carrier of active component and agriculture or forestry with the compound shown in the general formula I described in claim 1, as active component in the composition The weight content of the compound of general formula I is 1-99%. 8.一种控制植物病害的方法,其特征在于:将权利要求7所述的组合物以每公顷10克到1000克的有效剂量施于需要控制的病害或其生长的介质上。8. A method for controlling plant diseases, characterized in that: applying the composition according to claim 7 to the disease to be controlled or the medium in which it grows at an effective dose of 10 grams to 1000 grams per hectare.
CN201811496730.XA 2018-12-07 2018-12-07 Pyrazinamide compound and application thereof Pending CN111285815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811496730.XA CN111285815A (en) 2018-12-07 2018-12-07 Pyrazinamide compound and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811496730.XA CN111285815A (en) 2018-12-07 2018-12-07 Pyrazinamide compound and application thereof

Publications (1)

Publication Number Publication Date
CN111285815A true CN111285815A (en) 2020-06-16

Family

ID=71030553

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811496730.XA Pending CN111285815A (en) 2018-12-07 2018-12-07 Pyrazinamide compound and application thereof

Country Status (1)

Country Link
CN (1) CN111285815A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114685448A (en) * 2020-12-25 2022-07-01 江苏天士力帝益药业有限公司 Synthesis method of zopiclone impurity pyrazine-2-carboxylic acid (5-chloro-pyridin-2-yl) -amide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545099A2 (en) * 1991-11-22 1993-06-09 BASF Aktiengesellschaft Anilide derivatives and their use to combat Botrytis
WO2007125749A1 (en) * 2006-04-26 2007-11-08 Nihon Nohyaku Co., Ltd. Pyrazinecarboxamide derivative and plant disease-controlling agent comprising the same
CN104649973A (en) * 2013-11-25 2015-05-27 中国中化股份有限公司 Pyrazole amide compound and application thereof
CN106187893A (en) * 2015-05-06 2016-12-07 沈阳中化农药化工研发有限公司 A kind of pyrazol acid amide compounds and application thereof
CN108059613A (en) * 2016-11-09 2018-05-22 沈阳中化农药化工研发有限公司 A kind of pyrazol acid amide compounds and application

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545099A2 (en) * 1991-11-22 1993-06-09 BASF Aktiengesellschaft Anilide derivatives and their use to combat Botrytis
WO2007125749A1 (en) * 2006-04-26 2007-11-08 Nihon Nohyaku Co., Ltd. Pyrazinecarboxamide derivative and plant disease-controlling agent comprising the same
CN104649973A (en) * 2013-11-25 2015-05-27 中国中化股份有限公司 Pyrazole amide compound and application thereof
CN106187893A (en) * 2015-05-06 2016-12-07 沈阳中化农药化工研发有限公司 A kind of pyrazol acid amide compounds and application thereof
CN108059613A (en) * 2016-11-09 2018-05-22 沈阳中化农药化工研发有限公司 A kind of pyrazol acid amide compounds and application

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114685448A (en) * 2020-12-25 2022-07-01 江苏天士力帝益药业有限公司 Synthesis method of zopiclone impurity pyrazine-2-carboxylic acid (5-chloro-pyridin-2-yl) -amide

Similar Documents

Publication Publication Date Title
WO2015074614A1 (en) Pyrazole amide compound and use thereof
CN106187893B (en) A kind of pyrazol acid amide compounds and application thereof
CN102229573B (en) 1-(1,2,4-triazole-1-group)ketoxime ethers and its application in preparation of bactericide
CN108059614B (en) Pyrazole amide compound and application thereof
CN111285815A (en) Pyrazinamide compound and application thereof
CN108059613B (en) Pyrazole amide compound and application thereof
CN110963963A (en) A kind of pyridine amide compound and its bactericidal use
CN111285807B (en) Pyrazole amide compound and application thereof
CN111285801B (en) Pyridine amide compound and application
CN111285802B (en) Pyridine amide compound and application
CN106187939A (en) A kind of thiazole amide compound and application thereof
CN112624973B (en) Carboxylic acid ester compound and application thereof
CN107108515B (en) A kind of amide compound and its preparation method and use
CN108069905B (en) Pyrazole amide compound and application thereof
CN109867666B (en) Aromatic acetamide compound containing isothiazole ring and application thereof
CN106431977B (en) A kind of unsaturated oximido ethers compound and application thereof
CN120004819B (en) Difluoromethylthiazolamide compounds containing diphenyl ethers and their applications
DK179669B1 (en) Succinimide compound
CN108610283B (en) Secondary amine compound and preparation and application thereof
CN105254577B (en) A bistriazole-substituted phthalate compound, its preparation method and use
CN104649972B (en) A kind of pyrazol acid amide compounds and purposes
CN110724136A (en) Amide compound and its preparation method and application
CN109553615A (en) A kind of pyrimidine salt compounds and application thereof
KR100562371B1 (en) Azetidin-2-one derivatives substituted with dialkylsulfides useful as fungicides and preparation methods thereof
JPH09255624A (en) Bicyclo(3.3.0)octane derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200616

RJ01 Rejection of invention patent application after publication